Innovation is a collective endeavour.
Potential and strategic academic partners for infectious disease research, diagnostic development, epidemiological modelling, biomarker discovery, clinical research, and capacity building.
Potential clinical partners to evaluate our diagnostic technologies, generate clinical evidence, validate performance in routine settings, and support adoption into healthcare practice.
Potential public-sector partners such as Ministries of Health, national laboratories, and public health agencies to address priority diseases, strengthen diagnostic systems, support surveillance, and inform evidence-based health programmes.
Potential industry partners across the biotechnology and pharmaceutical value chain—from assay and product development to technology transfer, regulatory preparation, quality systems, manufacturing, and scale-up.
Potential technology partners to integrate artificial intelligence, data analytics, digital platforms, automation, and connected technologies into diagnostics and public health solutions.
Potential international organizations, foundations, development partners, and investors to mobilize technical and financial resources, accelerate regulatory and market access, and scale African-developed health technologies.
